Modified HEART score to optimize risk stratification in cocaine-associated chest pain

Published:January 14, 2021DOI:
      We recently reported in this journal that the classification performance of the HEART score is inferior in patients presenting with cocaine associated chest pain (CACP), with 14% of those with CACP in the low risk group experiencing adverse cardiac events within 30 days of indexed admission, compared to 4% in the general chest pain population.1 This finding suggests that the HEART score, in its current form, has limited clinical utility in stratifying risk in those evaluated for CACP in the emergency department (ED). Thus, we read with great interest the correspondence letter by Holmes et al. [
      • Holmes K.A.
      • Posey R.A.
      • Wang H.
      The value of using the HEART score among cocaine associated chest pain patients in the emergency department - a closer look.
      ] about our work, and we strongly agree with their views that an improved risk tool should be derived to better stratify risk in CACP. Such improved risk stratification in this group would have immediate clinical implications to everyday practice in emergency medicine.
      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Faramand Z.
        • Martin-Gill C.
        • Frisch S.O.
        • Callaway C.
        • Al-Zaiti S.
        The prognostic value of HEART score in patients with cocaine associated chest pain: an age-and-sex matched cohort study.
        Am J Emerg Med. 2020;
        • Holmes K.A.
        • Posey R.A.
        • Wang H.
        The value of using the HEART score among cocaine associated chest pain patients in the emergency department - a closer look.
        Am J Emerg Med. 2020;
        • McCord J.
        • Jneid H.
        • Hollander J.E.
        • et al.
        Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology.
        Circulation. 2008; 117: 1897-1907
        • Schwartz B.G.
        • Rezkalla S.
        • Kloner R.A.
        Cardiovascular effects of cocaine.
        Circulation. 2010; 122: 2558-2569
        • Gresnigt F.M.J.
        • Gubbels N.P.
        • Riezebos R.K.
        The current practice for cocaine-associated chest pain in the Netherlands.
        Toxicol Rep. 2021; 8: 23-27
        • Hollander J.E.
        • Hoffman R.S.
        • Gennis P.
        • et al.
        Prospective multicenter evaluation of cocaine-associated chest pain. Cocaine Associated Chest Pain (COCHPA) Study Group.
        Acad Emerg Med. 1994; 1: 330-339
        • Weber J.E.
        • Chudnofsky C.R.
        • Boczar M.
        • Boyer E.W.
        • Wilkerson M.D.
        • Hollander J.E.
        Cocaine-associated chest pain: how common is myocardial infarction?.
        Acad Emerg Med. 2000; 7: 873-877
        • Weber J.E.
        • Shofer F.S.
        • Larkin G.L.
        • Kalaria A.S.
        • Hollander J.E.
        Validation of a brief observation period for patients with cocaine-associated chest pain.
        N Engl J Med. 2003; 348: 510-517
        • Chase M.
        • Brown A.M.
        • Robey J.L.
        • et al.
        Application of the TIMI risk score in ED patients with cocaine-associated chest pain.
        Am J Emerg Med. 2007; 25: 1015-1018